BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9816262)

  • 1. Evaluation of transferrin and gallium-pyridoxal isonicotinoyl hydrazone as potential therapeutic agents to overcome lymphoid leukemic cell resistance to gallium nitrate.
    Chitambar CR; Boon P; Wereley JP
    Clin Cancer Res; 1996 Jun; 2(6):1009-15. PubMed ID: 9816262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallium-pyridoxal isonicotinoyl hydrazone (Ga-PIH), a novel cytotoxic gallium complex. A comparative study with gallium nitrate.
    Knorr GM; Chitambar CR
    Anticancer Res; 1998; 18(3A):1733-7. PubMed ID: 9673397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
    Richardson DR; Tran EH; Ponka P
    Blood; 1995 Dec; 86(11):4295-306. PubMed ID: 7492790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic analogs of the iron(III) chelator pyridoxal isonicotinoyl hydrazone: effects of complexation with copper(II), gallium(III), and iron (III) on their antiproliferative activities.
    Richardson DR
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2061-3. PubMed ID: 9303419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
    Richardson DR; Milnes K
    Blood; 1997 Apr; 89(8):3025-38. PubMed ID: 9108424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin receptor-dependent and -independent iron transport in gallium-resistant human lymphoid leukemic cells.
    Chitambar CR; Wereley JP
    Blood; 1998 Jun; 91(12):4686-93. PubMed ID: 9616166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hemoglobin production by transferrin-gallium.
    Chitambar CR; Zivkovic Z
    Blood; 1987 Jan; 69(1):144-9. PubMed ID: 3790721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
    Richardson DR; Ponka P
    J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.
    Baker E; Vitolo ML; Webb J
    Biochem Pharmacol; 1985 Sep; 34(17):3011-7. PubMed ID: 4038321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of drug resistance to gallium nitrate through modulation of cellular iron uptake.
    Chitambar CR; Zivkovic-Gilgenbach Z; Narasimhan J; Antholine WE
    Cancer Res; 1990 Aug; 50(15):4468-72. PubMed ID: 2164439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferric pyridoxal isonicotinoyl hydrazone can provide iron for heme synthesis in reticulocytes.
    Ponka P; Schulman HM; Wilczynska A
    Biochim Biophys Acta; 1982 Oct; 718(2):151-6. PubMed ID: 7138909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process.
    Richardson DR
    Biochim Biophys Acta; 1997 May; 1320(1):45-57. PubMed ID: 9186779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone.
    Cikrt M; Ponka P; Necas E; Neuwirt J
    Br J Haematol; 1980 Jun; 45(2):275-83. PubMed ID: 7437326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of gallium nitrate with fludarabine and iron chelators: effects on the proliferation of human leukemic HL60 cells.
    Lundberg JH; Chitambar CR
    Cancer Res; 1990 Oct; 50(20):6466-70. PubMed ID: 1698536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal.
    Hershko C; Avramovici-Grisaru S; Link G; Gelfand L; Sarel S
    J Lab Clin Med; 1981 Jul; 98(1):99-108. PubMed ID: 7252329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase.
    Green DA; Antholine WE; Wong SJ; Richardson DR; Chitambar CR
    Clin Cancer Res; 2001 Nov; 7(11):3574-9. PubMed ID: 11705879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells.
    Buss JL; Arduini E; Shephard KC; Ponka P
    Biochem Pharmacol; 2003 Feb; 65(3):349-60. PubMed ID: 12527328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs.
    Becker E; Richardson DR
    J Lab Clin Med; 1999 Nov; 134(5):510-21. PubMed ID: 10560945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cellular iron status on the release of soluble transferrin receptor from human promyelocytic leukemic HL60 cells.
    Chitambar CR; Zivkovic-Gilgenbach Z
    J Lab Clin Med; 1990 Sep; 116(3):345-53. PubMed ID: 2401848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of gallium compounds for treatment of lymphoma: gallium maltolate, a novel hydroxypyrone gallium compound, induces apoptosis and circumvents lymphoma cell resistance to gallium nitrate.
    Chitambar CR; Purpi DP; Woodliff J; Yang M; Wereley JP
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1228-36. PubMed ID: 17600139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.